Unknown

Dataset Information

0

Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial.


ABSTRACT:

Purpose

Urapidil is putatively effective for patients with hypertension and acute heart failure, although randomized controlled trials thereon are lacking. We investigated the efficacy and safety of intravenous urapidil relative to that of nitroglycerin in older patients with hypertension and heart failure in a randomized controlled trial.

Materials and methods

Patients (>60 y) with hypertension and heart failure were randomly assigned to receive intravenous urapidil (n=89) or nitroglycerin (n=91) for 7 days. Hemodynamic parameters, cardiac function, and safety outcomes were compared.

Results

Patients in the urapidil group had significantly lower mean systolic blood pressure (110.1±6.5 mm Hg) than those given nitroglycerin (126.4±8.1 mm Hg, p=0.022), without changes in heart rate. Urapidil was associated with improved cardiac function as reflected by lower N terminal-pro B type natriuretic peptide after 7 days (3311.4±546.1 ng/mL vs. 4879.1±325.7 ng/mL, p=0.027) and improved left ventricular ejection fraction (62.2±3.4% vs. 51.0±2.4%, p=0.032). Patients given urapidil had fewer associated adverse events, specifically headache (p=0.025) and tachycardia (p=0.004). The one-month rehospitalization and all-cause mortality rates were similar.

Conclusion

Intravenous administration of urapidil, compared with nitroglycerin, was associated with better control of blood pressure and preserved cardiac function, as well as fewer adverse events, for elderly patients with hypertension and acute heart failure.

SUBMITTER: Yang W 

PROVIDER: S-EPMC5122625 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial.

Yang Wei W   Zhou Yu Jie YJ   Fu Yan Y   Qin Jian J   Qin Shu S   Chen Xiao Min XM   Guo Jin Cheng JC   Wang De Zhao Z   Zhan Hong H   Li Jing J   He Jing Yu JY   Hua Qi Q  

Yonsei medical journal 20170101 1


<h4>Purpose</h4>Urapidil is putatively effective for patients with hypertension and acute heart failure, although randomized controlled trials thereon are lacking. We investigated the efficacy and safety of intravenous urapidil relative to that of nitroglycerin in older patients with hypertension and heart failure in a randomized controlled trial.<h4>Materials and methods</h4>Patients (>60 y) with hypertension and heart failure were randomly assigned to receive intravenous urapidil (n=89) or nit  ...[more]

Similar Datasets

| S-EPMC4438991 | biostudies-literature
| S-EPMC5560164 | biostudies-other
| S-EPMC8575262 | biostudies-literature
| S-EPMC5675712 | biostudies-literature
| S-EPMC7754944 | biostudies-literature
| S-EPMC6312052 | biostudies-literature
| S-EPMC7322585 | biostudies-literature
| S-EPMC2916661 | biostudies-literature
| S-EPMC8427168 | biostudies-literature
| S-EPMC8232441 | biostudies-literature